Stay updated with breaking news from Malin carlsson. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
TietoEVRY Oyj (via Public) / Leasing solution supports the city of Gothenburg for greener operations publicnow.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from publicnow.com Daily Mail and Mail on Sunday newspapers.
Märkligt att omställningsstödet till politiker inte ses över bt.se - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bt.se Daily Mail and Mail on Sunday newspapers.
Share: LUND, Sweden, May 5, 2021 /PRNewswire/ Alligator Bioscience (Nasdaq Stockholm: ATORX) today announced that preclinical data on its agonist anti-CD40 antibody mitazalimab has been published in the scientific journal Cancer Immunology, Immunotherapy. The published data show that mitazalimab activates dendritic cells and tumor-reactive T cells resulting in enhanced anti-tumor efficacy in combination with a model cancer vaccine. Title: The human anti-CD40 agonist antibody mitazalimab (ADC-1013; JNJ-64457107) activates antigen-presenting cells, improves expansion of antigen-specific T cells and enhances anti-tumor efficacy of a model cancer vaccine in vivo Journal: Cancer Immunology, Immunotherapy Authors: Adnan Deronic et al. A publication in a prominent peer-reviewed journal such as Cancer Immunology, Immunotherapy is very encouraging and validates our findings. These data further highlight the strong potential for mitazalimab to be comb ....
Alligator Bioscience and BioArctic enter into research agreement in the neurodegenerative field LUND, Sweden, May 4, 2021 /PRNewswire/ Alligator Bioscience (Nasdaq Stockholm: ATORX) today announced that it has entered into a joint research agreement with BioArctic AB, a Swedish research-based biopharma company focusing on disease-modifying treatments and reliable biomarkers and diagnostics for neurodegenerative diseases, such as Alzheimer s disease and Parkinson s disease. Under the agreement, Alligator will employ its proprietary antibody generation technologies in collaboration with BioArctic to develop new product candidates. We are very pleased that BioArctic has recognized the power of Alligator s proprietary phage display libraries which have been successfully used to generate Alligator s suite of immuno-oncology programs. The application of this technology to the neurodegenerative field demonstrates the broad applicability of our powerful platform, said Mal ....